nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—Lisinopril—systemic scleroderma	0.0453	0.17	CbGbCtD
Quetiapine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0411	0.154	CbGbCtD
Quetiapine—ABCB1—Captopril—systemic scleroderma	0.0339	0.127	CbGbCtD
Quetiapine—CYP2D6—Captopril—systemic scleroderma	0.032	0.12	CbGbCtD
Quetiapine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0267	0.1	CbGbCtD
Quetiapine—CYP2C19—Prednisone—systemic scleroderma	0.0265	0.0994	CbGbCtD
Quetiapine—ABCB1—Prednisone—systemic scleroderma	0.0214	0.0802	CbGbCtD
Quetiapine—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0212	0.155	CbGeAlD
Quetiapine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.016	0.0601	CbGbCtD
Quetiapine—HTR7—myenteric nerve plexus—systemic scleroderma	0.0137	0.1	CbGeAlD
Quetiapine—CYP3A4—Prednisone—systemic scleroderma	0.0128	0.048	CbGbCtD
Quetiapine—ABCB1—Methotrexate—systemic scleroderma	0.0107	0.0402	CbGbCtD
Quetiapine—HTR7—pulmonary artery—systemic scleroderma	0.0097	0.071	CbGeAlD
Quetiapine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00854	0.0625	CbGeAlD
Quetiapine—HTR2A—pulmonary artery—systemic scleroderma	0.00605	0.0443	CbGeAlD
Quetiapine—HTR1B—artery—systemic scleroderma	0.00466	0.0341	CbGeAlD
Quetiapine—HTR1D—artery—systemic scleroderma	0.00451	0.033	CbGeAlD
Quetiapine—HTR1B—blood vessel—systemic scleroderma	0.00363	0.0266	CbGeAlD
Quetiapine—HTR7—artery—systemic scleroderma	0.00359	0.0263	CbGeAlD
Quetiapine—HTR1D—blood vessel—systemic scleroderma	0.00351	0.0257	CbGeAlD
Quetiapine—HTR7—endothelium—systemic scleroderma	0.00304	0.0222	CbGeAlD
Quetiapine—HTR7—blood vessel—systemic scleroderma	0.0028	0.0205	CbGeAlD
Quetiapine—CHRM5—skin of body—systemic scleroderma	0.00244	0.0178	CbGeAlD
Quetiapine—H1F0—connective tissue—systemic scleroderma	0.00233	0.017	CbGeAlD
Quetiapine—HTR2A—artery—systemic scleroderma	0.00224	0.0164	CbGeAlD
Quetiapine—H1F0—smooth muscle tissue—systemic scleroderma	0.00213	0.0156	CbGeAlD
Quetiapine—H1F0—skin of body—systemic scleroderma	0.0021	0.0154	CbGeAlD
Quetiapine—HTR2A—endothelium—systemic scleroderma	0.00189	0.0139	CbGeAlD
Quetiapine—HTR1D—connective tissue—systemic scleroderma	0.0018	0.0132	CbGeAlD
Quetiapine—HTR2A—blood vessel—systemic scleroderma	0.00175	0.0128	CbGeAlD
Quetiapine—H1F0—digestive system—systemic scleroderma	0.00168	0.0123	CbGeAlD
Quetiapine—HTR3A—digestive system—systemic scleroderma	0.0016	0.0117	CbGeAlD
Quetiapine—H1F0—tendon—systemic scleroderma	0.0016	0.0117	CbGeAlD
Quetiapine—HTR7—connective tissue—systemic scleroderma	0.00144	0.0105	CbGeAlD
Quetiapine—H1F0—lung—systemic scleroderma	0.0014	0.0103	CbGeAlD
Quetiapine—CHRM3—smooth muscle tissue—systemic scleroderma	0.00138	0.0101	CbGeAlD
Quetiapine—HTR3A—lung—systemic scleroderma	0.00134	0.0098	CbGeAlD
Quetiapine—HTR7—smooth muscle tissue—systemic scleroderma	0.00131	0.00962	CbGeAlD
Quetiapine—ABCB1—blood vessel—systemic scleroderma	0.00114	0.00838	CbGeAlD
Quetiapine—CHRM3—digestive system—systemic scleroderma	0.00109	0.00798	CbGeAlD
Quetiapine—HRH1—connective tissue—systemic scleroderma	0.00107	0.00785	CbGeAlD
Quetiapine—ADRA2A—connective tissue—systemic scleroderma	0.00105	0.00771	CbGeAlD
Quetiapine—HTR7—digestive system—systemic scleroderma	0.00104	0.00759	CbGeAlD
Quetiapine—CHRM1—lung—systemic scleroderma	0.00102	0.00744	CbGeAlD
Quetiapine—CYP2C19—digestive system—systemic scleroderma	0.00101	0.00741	CbGeAlD
Quetiapine—HTR7—tendon—systemic scleroderma	0.000987	0.00723	CbGeAlD
Quetiapine—HRH1—smooth muscle tissue—systemic scleroderma	0.000981	0.00718	CbGeAlD
Quetiapine—ADRA2C—tendon—systemic scleroderma	0.000907	0.00664	CbGeAlD
Quetiapine—HTR2A—connective tissue—systemic scleroderma	0.000895	0.00656	CbGeAlD
Quetiapine—HTR7—lung—systemic scleroderma	0.000866	0.00634	CbGeAlD
Quetiapine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000819	0.006	CbGeAlD
Quetiapine—DRD2—lung—systemic scleroderma	0.000819	0.006	CbGeAlD
Quetiapine—CYP3A5—digestive system—systemic scleroderma	0.000798	0.00584	CbGeAlD
Quetiapine—ADRA2C—lung—systemic scleroderma	0.000796	0.00583	CbGeAlD
Quetiapine—HRH1—digestive system—systemic scleroderma	0.000774	0.00567	CbGeAlD
Quetiapine—HRH1—tendon—systemic scleroderma	0.000737	0.0054	CbGeAlD
Quetiapine—ADRA2A—tendon—systemic scleroderma	0.000724	0.0053	CbGeAlD
Quetiapine—CYP3A5—lung—systemic scleroderma	0.000666	0.00488	CbGeAlD
Quetiapine—HTR2A—digestive system—systemic scleroderma	0.000647	0.00473	CbGeAlD
Quetiapine—HRH1—lung—systemic scleroderma	0.000647	0.00473	CbGeAlD
Quetiapine—ADRA2A—lung—systemic scleroderma	0.000635	0.00465	CbGeAlD
Quetiapine—HTR2A—tendon—systemic scleroderma	0.000615	0.00451	CbGeAlD
Quetiapine—CYP3A4—digestive system—systemic scleroderma	0.000599	0.00438	CbGeAlD
Quetiapine—CYP2D6—digestive system—systemic scleroderma	0.000589	0.00431	CbGeAlD
Quetiapine—HTR2A—lung—systemic scleroderma	0.00054	0.00395	CbGeAlD
Quetiapine—ABCB1—digestive system—systemic scleroderma	0.000424	0.0031	CbGeAlD
Quetiapine—ABCB1—lung—systemic scleroderma	0.000354	0.00259	CbGeAlD
Quetiapine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000239	0.0004	CcSEcCtD
Quetiapine—Depression—Prednisone—systemic scleroderma	0.000239	0.0004	CcSEcCtD
Quetiapine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000399	CcSEcCtD
Quetiapine—Body temperature increased—Leflunomide—systemic scleroderma	0.000236	0.000396	CcSEcCtD
Quetiapine—Abdominal pain—Leflunomide—systemic scleroderma	0.000236	0.000396	CcSEcCtD
Quetiapine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000235	0.000394	CcSEcCtD
Quetiapine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000393	CcSEcCtD
Quetiapine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000393	CcSEcCtD
Quetiapine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000393	CcSEcCtD
Quetiapine—Breast disorder—Methotrexate—systemic scleroderma	0.000235	0.000393	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000234	0.000392	CcSEcCtD
Quetiapine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000392	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000234	0.000391	CcSEcCtD
Quetiapine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000233	0.000391	CcSEcCtD
Quetiapine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000233	0.000391	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000391	CcSEcCtD
Quetiapine—Insomnia—Lisinopril—systemic scleroderma	0.000232	0.000389	CcSEcCtD
Quetiapine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000389	CcSEcCtD
Quetiapine—Paraesthesia—Lisinopril—systemic scleroderma	0.000231	0.000387	CcSEcCtD
Quetiapine—Vomiting—Captopril—systemic scleroderma	0.000231	0.000386	CcSEcCtD
Quetiapine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000385	CcSEcCtD
Quetiapine—Dyspnoea—Lisinopril—systemic scleroderma	0.000229	0.000384	CcSEcCtD
Quetiapine—Rash—Captopril—systemic scleroderma	0.000229	0.000383	CcSEcCtD
Quetiapine—Dermatitis—Captopril—systemic scleroderma	0.000229	0.000383	CcSEcCtD
Quetiapine—Somnolence—Lisinopril—systemic scleroderma	0.000228	0.000383	CcSEcCtD
Quetiapine—Headache—Captopril—systemic scleroderma	0.000227	0.000381	CcSEcCtD
Quetiapine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00038	CcSEcCtD
Quetiapine—Dyspepsia—Lisinopril—systemic scleroderma	0.000226	0.000379	CcSEcCtD
Quetiapine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000226	0.000378	CcSEcCtD
Quetiapine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000226	0.000378	CcSEcCtD
Quetiapine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000377	CcSEcCtD
Quetiapine—Asthma—Methotrexate—systemic scleroderma	0.000224	0.000376	CcSEcCtD
Quetiapine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000375	CcSEcCtD
Quetiapine—Decreased appetite—Lisinopril—systemic scleroderma	0.000223	0.000374	CcSEcCtD
Quetiapine—Eosinophilia—Methotrexate—systemic scleroderma	0.000222	0.000372	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000222	0.000372	CcSEcCtD
Quetiapine—Fatigue—Lisinopril—systemic scleroderma	0.000222	0.000371	CcSEcCtD
Quetiapine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000371	CcSEcCtD
Quetiapine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00037	CcSEcCtD
Quetiapine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000369	CcSEcCtD
Quetiapine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00022	0.000369	CcSEcCtD
Quetiapine—Pancreatitis—Methotrexate—systemic scleroderma	0.00022	0.000368	CcSEcCtD
Quetiapine—Constipation—Lisinopril—systemic scleroderma	0.00022	0.000368	CcSEcCtD
Quetiapine—Pain—Lisinopril—systemic scleroderma	0.00022	0.000368	CcSEcCtD
Quetiapine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000368	CcSEcCtD
Quetiapine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000366	CcSEcCtD
Quetiapine—Bradycardia—Prednisone—systemic scleroderma	0.000219	0.000366	CcSEcCtD
Quetiapine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000365	CcSEcCtD
Quetiapine—Diarrhoea—Azathioprine—systemic scleroderma	0.000217	0.000363	CcSEcCtD
Quetiapine—Haemoglobin—Prednisone—systemic scleroderma	0.000216	0.000362	CcSEcCtD
Quetiapine—Nausea—Captopril—systemic scleroderma	0.000216	0.000361	CcSEcCtD
Quetiapine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000215	0.00036	CcSEcCtD
Quetiapine—Haemorrhage—Prednisone—systemic scleroderma	0.000215	0.00036	CcSEcCtD
Quetiapine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00036	CcSEcCtD
Quetiapine—Asthenia—Leflunomide—systemic scleroderma	0.000215	0.000359	CcSEcCtD
Quetiapine—Hallucination—Prednisone—systemic scleroderma	0.000214	0.000358	CcSEcCtD
Quetiapine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000212	0.000355	CcSEcCtD
Quetiapine—Pruritus—Leflunomide—systemic scleroderma	0.000212	0.000354	CcSEcCtD
Quetiapine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000211	0.000354	CcSEcCtD
Quetiapine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000352	CcSEcCtD
Quetiapine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00021	0.000352	CcSEcCtD
Quetiapine—Dysuria—Methotrexate—systemic scleroderma	0.00021	0.000351	CcSEcCtD
Quetiapine—Neutropenia—Methotrexate—systemic scleroderma	0.00021	0.000351	CcSEcCtD
Quetiapine—Dizziness—Azathioprine—systemic scleroderma	0.000209	0.000351	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000209	0.000349	CcSEcCtD
Quetiapine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000207	0.000346	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000344	CcSEcCtD
Quetiapine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000205	0.000343	CcSEcCtD
Quetiapine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000205	0.000343	CcSEcCtD
Quetiapine—Diarrhoea—Leflunomide—systemic scleroderma	0.000205	0.000343	CcSEcCtD
Quetiapine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000341	CcSEcCtD
Quetiapine—Abdominal pain—Lisinopril—systemic scleroderma	0.000203	0.00034	CcSEcCtD
Quetiapine—Body temperature increased—Lisinopril—systemic scleroderma	0.000203	0.00034	CcSEcCtD
Quetiapine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000339	CcSEcCtD
Quetiapine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000202	0.000338	CcSEcCtD
Quetiapine—Vomiting—Azathioprine—systemic scleroderma	0.000201	0.000337	CcSEcCtD
Quetiapine—Pneumonia—Methotrexate—systemic scleroderma	0.000201	0.000337	CcSEcCtD
Quetiapine—Eye disorder—Prednisone—systemic scleroderma	0.000201	0.000336	CcSEcCtD
Quetiapine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000336	CcSEcCtD
Quetiapine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000335	CcSEcCtD
Quetiapine—Infestation NOS—Methotrexate—systemic scleroderma	0.0002	0.000335	CcSEcCtD
Quetiapine—Infestation—Methotrexate—systemic scleroderma	0.0002	0.000335	CcSEcCtD
Quetiapine—Rash—Azathioprine—systemic scleroderma	0.0002	0.000334	CcSEcCtD
Quetiapine—Dermatitis—Azathioprine—systemic scleroderma	0.0002	0.000334	CcSEcCtD
Quetiapine—Depression—Methotrexate—systemic scleroderma	0.000199	0.000334	CcSEcCtD
Quetiapine—Headache—Azathioprine—systemic scleroderma	0.000198	0.000332	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000198	0.000332	CcSEcCtD
Quetiapine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000332	CcSEcCtD
Quetiapine—Dizziness—Leflunomide—systemic scleroderma	0.000198	0.000331	CcSEcCtD
Quetiapine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000328	CcSEcCtD
Quetiapine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000195	0.000327	CcSEcCtD
Quetiapine—Stomatitis—Methotrexate—systemic scleroderma	0.000195	0.000327	CcSEcCtD
Quetiapine—Angiopathy—Prednisone—systemic scleroderma	0.000195	0.000326	CcSEcCtD
Quetiapine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000194	0.000326	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000326	CcSEcCtD
Quetiapine—Immune system disorder—Prednisone—systemic scleroderma	0.000194	0.000325	CcSEcCtD
Quetiapine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000323	CcSEcCtD
Quetiapine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000323	CcSEcCtD
Quetiapine—Sweating—Methotrexate—systemic scleroderma	0.000192	0.000321	CcSEcCtD
Quetiapine—Vomiting—Leflunomide—systemic scleroderma	0.00019	0.000319	CcSEcCtD
Quetiapine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000189	0.000317	CcSEcCtD
Quetiapine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000189	0.000317	CcSEcCtD
Quetiapine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000189	0.000316	CcSEcCtD
Quetiapine—Epistaxis—Methotrexate—systemic scleroderma	0.000189	0.000316	CcSEcCtD
Quetiapine—Rash—Leflunomide—systemic scleroderma	0.000189	0.000316	CcSEcCtD
Quetiapine—Dermatitis—Leflunomide—systemic scleroderma	0.000188	0.000316	CcSEcCtD
Quetiapine—Mental disorder—Prednisone—systemic scleroderma	0.000188	0.000315	CcSEcCtD
Quetiapine—Nausea—Azathioprine—systemic scleroderma	0.000188	0.000315	CcSEcCtD
Quetiapine—Headache—Leflunomide—systemic scleroderma	0.000187	0.000314	CcSEcCtD
Quetiapine—Malnutrition—Prednisone—systemic scleroderma	0.000187	0.000313	CcSEcCtD
Quetiapine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000187	0.000313	CcSEcCtD
Quetiapine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000311	CcSEcCtD
Quetiapine—Asthenia—Lisinopril—systemic scleroderma	0.000184	0.000309	CcSEcCtD
Quetiapine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000308	CcSEcCtD
Quetiapine—Pruritus—Lisinopril—systemic scleroderma	0.000182	0.000305	CcSEcCtD
Quetiapine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000181	0.000304	CcSEcCtD
Quetiapine—Haemoglobin—Methotrexate—systemic scleroderma	0.00018	0.000302	CcSEcCtD
Quetiapine—Rash—Mycophenolic acid—systemic scleroderma	0.00018	0.000301	CcSEcCtD
Quetiapine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00018	0.000301	CcSEcCtD
Quetiapine—Haemorrhage—Methotrexate—systemic scleroderma	0.00018	0.000301	CcSEcCtD
Quetiapine—Hepatitis—Methotrexate—systemic scleroderma	0.00018	0.000301	CcSEcCtD
Quetiapine—Headache—Mycophenolic acid—systemic scleroderma	0.000179	0.000299	CcSEcCtD
Quetiapine—Pharyngitis—Methotrexate—systemic scleroderma	0.000178	0.000298	CcSEcCtD
Quetiapine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000298	CcSEcCtD
Quetiapine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000298	CcSEcCtD
Quetiapine—Nausea—Leflunomide—systemic scleroderma	0.000178	0.000298	CcSEcCtD
Quetiapine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000177	0.000297	CcSEcCtD
Quetiapine—Vision blurred—Prednisone—systemic scleroderma	0.000176	0.000295	CcSEcCtD
Quetiapine—Urethral disorder—Methotrexate—systemic scleroderma	0.000176	0.000295	CcSEcCtD
Quetiapine—Diarrhoea—Lisinopril—systemic scleroderma	0.000176	0.000295	CcSEcCtD
Quetiapine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000174	0.000291	CcSEcCtD
Quetiapine—Visual impairment—Methotrexate—systemic scleroderma	0.000173	0.00029	CcSEcCtD
Quetiapine—Anaemia—Prednisone—systemic scleroderma	0.000173	0.00029	CcSEcCtD
Quetiapine—Agitation—Prednisone—systemic scleroderma	0.000172	0.000288	CcSEcCtD
Quetiapine—Angioedema—Prednisone—systemic scleroderma	0.000171	0.000286	CcSEcCtD
Quetiapine—Dizziness—Lisinopril—systemic scleroderma	0.00017	0.000285	CcSEcCtD
Quetiapine—Erythema multiforme—Methotrexate—systemic scleroderma	0.00017	0.000284	CcSEcCtD
Quetiapine—Nausea—Mycophenolic acid—systemic scleroderma	0.000169	0.000284	CcSEcCtD
Quetiapine—Malaise—Prednisone—systemic scleroderma	0.000169	0.000282	CcSEcCtD
Quetiapine—Vertigo—Prednisone—systemic scleroderma	0.000168	0.000281	CcSEcCtD
Quetiapine—Eye disorder—Methotrexate—systemic scleroderma	0.000168	0.000281	CcSEcCtD
Quetiapine—Syncope—Prednisone—systemic scleroderma	0.000168	0.000281	CcSEcCtD
Quetiapine—Tinnitus—Methotrexate—systemic scleroderma	0.000167	0.00028	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000167	0.000279	CcSEcCtD
Quetiapine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000278	CcSEcCtD
Quetiapine—Loss of consciousness—Prednisone—systemic scleroderma	0.000164	0.000275	CcSEcCtD
Quetiapine—Vomiting—Lisinopril—systemic scleroderma	0.000163	0.000274	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—systemic scleroderma	0.000163	0.000273	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—systemic scleroderma	0.000162	0.000272	CcSEcCtD
Quetiapine—Rash—Lisinopril—systemic scleroderma	0.000162	0.000271	CcSEcCtD
Quetiapine—Convulsion—Prednisone—systemic scleroderma	0.000162	0.000271	CcSEcCtD
Quetiapine—Dermatitis—Lisinopril—systemic scleroderma	0.000162	0.000271	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000162	0.000271	CcSEcCtD
Quetiapine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000271	CcSEcCtD
Quetiapine—Hypertension—Prednisone—systemic scleroderma	0.000161	0.00027	CcSEcCtD
Quetiapine—Chills—Methotrexate—systemic scleroderma	0.000161	0.00027	CcSEcCtD
Quetiapine—Headache—Lisinopril—systemic scleroderma	0.000161	0.00027	CcSEcCtD
Quetiapine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000267	CcSEcCtD
Quetiapine—Arthralgia—Prednisone—systemic scleroderma	0.000159	0.000267	CcSEcCtD
Quetiapine—Myalgia—Prednisone—systemic scleroderma	0.000159	0.000267	CcSEcCtD
Quetiapine—Anxiety—Prednisone—systemic scleroderma	0.000159	0.000266	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000158	0.000265	CcSEcCtD
Quetiapine—Discomfort—Prednisone—systemic scleroderma	0.000157	0.000263	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—systemic scleroderma	0.000157	0.000263	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—systemic scleroderma	0.000156	0.000262	CcSEcCtD
Quetiapine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000258	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—systemic scleroderma	0.000153	0.000256	CcSEcCtD
Quetiapine—Nausea—Lisinopril—systemic scleroderma	0.000153	0.000256	CcSEcCtD
Quetiapine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000153	0.000256	CcSEcCtD
Quetiapine—Infection—Prednisone—systemic scleroderma	0.000152	0.000254	CcSEcCtD
Quetiapine—Back pain—Methotrexate—systemic scleroderma	0.000151	0.000253	CcSEcCtD
Quetiapine—Shock—Prednisone—systemic scleroderma	0.00015	0.000252	CcSEcCtD
Quetiapine—Nervous system disorder—Prednisone—systemic scleroderma	0.00015	0.000251	CcSEcCtD
Quetiapine—Tachycardia—Prednisone—systemic scleroderma	0.000149	0.00025	CcSEcCtD
Quetiapine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000249	CcSEcCtD
Quetiapine—Skin disorder—Prednisone—systemic scleroderma	0.000148	0.000248	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000148	0.000247	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—systemic scleroderma	0.000147	0.000247	CcSEcCtD
Quetiapine—Anorexia—Prednisone—systemic scleroderma	0.000146	0.000244	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000145	0.000243	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—systemic scleroderma	0.000144	0.000242	CcSEcCtD
Quetiapine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000143	0.00024	CcSEcCtD
Quetiapine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000238	CcSEcCtD
Quetiapine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000238	CcSEcCtD
Quetiapine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000236	CcSEcCtD
Quetiapine—Malaise—Methotrexate—systemic scleroderma	0.000141	0.000236	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—systemic scleroderma	0.00014	0.000235	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—systemic scleroderma	0.00014	0.000234	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000139	0.000233	CcSEcCtD
Quetiapine—Insomnia—Prednisone—systemic scleroderma	0.000138	0.000231	CcSEcCtD
Quetiapine—Paraesthesia—Prednisone—systemic scleroderma	0.000137	0.00023	CcSEcCtD
Quetiapine—Cough—Methotrexate—systemic scleroderma	0.000136	0.000228	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—systemic scleroderma	0.000135	0.000227	CcSEcCtD
Quetiapine—Dyspepsia—Prednisone—systemic scleroderma	0.000134	0.000225	CcSEcCtD
Quetiapine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000224	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—systemic scleroderma	0.000133	0.000223	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—systemic scleroderma	0.000133	0.000223	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—systemic scleroderma	0.000133	0.000223	CcSEcCtD
Quetiapine—Decreased appetite—Prednisone—systemic scleroderma	0.000133	0.000222	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000132	0.000221	CcSEcCtD
Quetiapine—Fatigue—Prednisone—systemic scleroderma	0.000132	0.00022	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—systemic scleroderma	0.000131	0.00022	CcSEcCtD
Quetiapine—Constipation—Prednisone—systemic scleroderma	0.000131	0.000219	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—systemic scleroderma	0.000129	0.000215	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000128	0.000214	CcSEcCtD
Quetiapine—Infection—Methotrexate—systemic scleroderma	0.000127	0.000212	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisone—systemic scleroderma	0.000126	0.000211	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000125	0.00021	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000125	0.000209	CcSEcCtD
Quetiapine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000125	0.000209	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—systemic scleroderma	0.000124	0.000208	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000123	0.000207	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—systemic scleroderma	0.000122	0.000204	CcSEcCtD
Quetiapine—Body temperature increased—Prednisone—systemic scleroderma	0.000121	0.000202	CcSEcCtD
Quetiapine—Abdominal pain—Prednisone—systemic scleroderma	0.000121	0.000202	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—systemic scleroderma	0.000119	0.0002	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000116	0.000195	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—systemic scleroderma	0.000115	0.000193	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—systemic scleroderma	0.000115	0.000192	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—systemic scleroderma	0.000114	0.00019	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—systemic scleroderma	0.000113	0.00019	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisone—systemic scleroderma	0.000112	0.000188	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—systemic scleroderma	0.000112	0.000188	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—systemic scleroderma	0.000111	0.000186	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00011	0.000184	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—systemic scleroderma	0.00011	0.000184	CcSEcCtD
Quetiapine—Asthenia—Prednisone—systemic scleroderma	0.00011	0.000183	CcSEcCtD
Quetiapine—Pain—Methotrexate—systemic scleroderma	0.000109	0.000183	CcSEcCtD
Quetiapine—Pruritus—Prednisone—systemic scleroderma	0.000108	0.000181	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000105	0.000176	CcSEcCtD
Quetiapine—Diarrhoea—Prednisone—systemic scleroderma	0.000104	0.000175	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000104	0.000175	CcSEcCtD
Quetiapine—Dizziness—Prednisone—systemic scleroderma	0.000101	0.000169	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—systemic scleroderma	0.000101	0.000169	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—systemic scleroderma	0.000101	0.000169	CcSEcCtD
Quetiapine—Vomiting—Prednisone—systemic scleroderma	9.71e-05	0.000163	CcSEcCtD
Quetiapine—Rash—Prednisone—systemic scleroderma	9.62e-05	0.000161	CcSEcCtD
Quetiapine—Dermatitis—Prednisone—systemic scleroderma	9.62e-05	0.000161	CcSEcCtD
Quetiapine—Headache—Prednisone—systemic scleroderma	9.56e-05	0.00016	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—systemic scleroderma	9.4e-05	0.000157	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—systemic scleroderma	9.15e-05	0.000153	CcSEcCtD
Quetiapine—Nausea—Prednisone—systemic scleroderma	9.07e-05	0.000152	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—systemic scleroderma	9.03e-05	0.000151	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—systemic scleroderma	8.73e-05	0.000146	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—systemic scleroderma	8.44e-05	0.000141	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—systemic scleroderma	8.11e-05	0.000136	CcSEcCtD
Quetiapine—Rash—Methotrexate—systemic scleroderma	8.04e-05	0.000135	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—systemic scleroderma	8.04e-05	0.000135	CcSEcCtD
Quetiapine—Headache—Methotrexate—systemic scleroderma	7.99e-05	0.000134	CcSEcCtD
Quetiapine—Nausea—Methotrexate—systemic scleroderma	7.58e-05	0.000127	CcSEcCtD
